Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Update

5 Feb 2018 07:14

RNS Number : 8852D
Electrocomponents PLC
05 February 2018
 

 

Electrocomponents plc today issues a trading update for the four-month period to 31 January 2018.

 

Underlying revenue growth(1)

Region

Q1 to June 2017

Q2 to Sept 2017

4 months to 31 Jan 2018

 

Northern Europe

 

10%

 

12%

13%

Southern Europe

10%

12%

11%

Central Europe

11%

14%

17%

Total Europe

10%

13%

13%

Asia Pacific

18%

17%

22%

The Americas

16%

15%

12%

Group

13%

14%

14%

 

Our strong underlying revenue (1) performance in H1 has continued into the first four months of H2. The market backdrop remains positive and we continue to execute well with improvements in areas such as customer experience, digital and sales effectiveness driving further market share gains.

· In the four months to 31 January 2018, Group underlying revenue growth remained strong at 14%, with all of our five regions continuing to see double-digit underlying revenue growth.

o Strong momentum in digital with 15% underlying revenue growth in the period reflecting success with our digital marketing strategy and improved online experience.

o A further acceleration in underlying revenue growth at RS Pro, our own-brand business, which grew at 14% during the period (+10% in H1).

· We remain on track to deliver stable gross margin for the full year to March 2018.

· At the end of this financial year we will have completed the first phase of the Performance Improvement Plan and delivered cumulative annualised savings of £30 million. We are currently examining new initiatives to further simplify the way we do business and generate efficiency.

 

Lindsley Ruth, Chief Executive Officer, commented

"Our performance year to date has been pleasing and we are confident of delivering strong progress in the current financial year. The first phase of the Performance Improvement Plan is now complete, but we still believe we have a significant further opportunity to improve efficiency and reduce complexity allowing continued strong growth at higher operating margins. We remain excited by the opportunity for growth and improvement."

 

LEI: 549300KVXDURRKVW7R37

 

Enquiries:

David Egan

Group Finance Director

0207 239 8400

Polly Elvin

Investor Relations and Corporate PR

0207 239 8427

Martin Robinson/David Allchurch

Tulchan Communications

0207 353 4200

 

Notes:

1. Revenue growth rates, unless otherwise stated, are adjusted for trading days and currency movements ("underlying revenue growth/decline").

2. During the year to March 2018 we expect to see around a £24 million adverse impact on revenue from fewer trading days compared with FY 2017. In the year to March 2019 we expect to see a positive impact of around £9 million on revenue from additional trading days compared with FY 2018.

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. The average H1 exchange rates for Euro and US $ respectively were €1.14 and $1.29. Ten months to 31 January average spot rates for Euro and US $ respectively are €1.13 and $1.31. Assuming 31 January spot rates continue for the balance of the year our average exchange rates for Euro and US $ for the year would be €1.13 and $1.32. Every 1 cent movement in the Euro will have a circa £1.2 million impact on profit. Every 1 cent movement in US $ will have a circa £0.4 million impact on profit.

 

 

 

Electrocomponents plc - Conference Call Dial in Instructions

Date:

Monday 5 February

UK Time:

08.00h call

Telephone number:

+44 (0) 1452 541003

PIN:

9377237

Chairman:

Lindsley Ruth

Electrocomponents plc - Replay Dial in Instructions (available until Monday 12 February)

Telephone number:

+44 (0) 1452 550000

PIN:

9377237

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVABRWAAURRR
Date   Source Headline
1st Feb 201610:06 amRNSBlocklisting Interim Review
21st Jan 201611:34 amRNSNotice of trading update
4th Jan 20169:13 amRNSTotal Voting Rights
14th Dec 20157:00 amRNSDirectorate Change
1st Dec 201510:15 amRNSHolding(s) in Company
30th Nov 20159:31 amRNSTotal Voting Rights
25th Nov 201511:36 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSFY16 Half-year Financial Report
30th Oct 201510:16 amRNSTotal Voting Rights
9th Oct 20159:35 amRNSHolding(s) in Company
2nd Oct 20157:00 amRNSTrading Update
30th Sep 20152:43 pmRNSDirectorate Change
30th Sep 201511:55 amRNSTotal Voting Rights
24th Sep 201510:46 amRNSNotice of Trading Update
23rd Sep 201511:19 amRNSHolding(s) in Company
8th Sep 201510:47 amRNSChange of Adviser
4th Aug 20154:02 pmRNSAdditional Listing
31st Jul 201511:00 amRNSBlocklisting Interim Review
23rd Jul 20151:57 pmRNSResult of AGM
23rd Jul 20157:00 amRNSFirst Quarter Trading Statement
16th Jul 20159:16 amRNSHolding(s) in Company
6th Jul 20151:43 pmRNSDirector/PDMR Shareholding
1st Jul 20151:33 pmRNSDirector/PDMR Shareholding
30th Jun 201510:34 amRNSTotal Voting Rights
24th Jun 20153:55 pmRNSDirector/PDMR Shareholding
24th Jun 20159:53 amRNSDirector/PDMR Shareholding
19th Jun 201510:31 amRNSNotice of trading update
16th Jun 20152:54 pmRNSAnnual Financial Report
1st Jun 20159:52 amRNSHolding(s) in Company
21st May 20153:10 pmRNSDirector/PDMR Shareholding
21st May 20157:00 amRNSDirectorate Change
21st May 20157:00 amRNSFinal Results
7th May 201510:13 amRNSDirectorate Change
7th May 201510:11 amRNSDirectorate Change
30th Apr 201511:21 amRNSTotal Voting Rights
2nd Apr 20157:00 amRNSTrading Statement
1st Apr 20153:10 pmRNSDirectorate Change
31st Mar 20154:49 pmRNSDirectorate Change
31st Mar 20151:46 pmRNSTotal Voting Rights
13th Mar 20159:26 amRNSNotice of Trading Update
2nd Mar 20152:51 pmRNSDirector/PDMR Shareholding
2nd Mar 201512:24 pmRNSTotal Voting Rights
27th Feb 201510:12 amRNSDirector Declaration
27th Feb 20157:00 amRNSDirectorate Change
11th Feb 20157:00 amRNSTrading Statement
6th Feb 20153:22 pmRNSTotal Voting Rights
6th Feb 20153:01 pmRNSBlocklisting Interim Review
2nd Feb 20152:57 pmRNSBlocklisting Interim Review
2nd Feb 20152:51 pmRNSTotal Voting Rights
15th Jan 20159:47 amRNSNotice of interim management statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.